pharmacokinetics of glp-1 receptor agonists and the kidney: from physiology to pharmacology and outcomes in diabetes GLP-1-based therapies for type 2

Discover The Key Differences And Benefits Of Mounjaro And Ozempic For Weight Loss By Dr

Discover clinical trial results and which GLP-1 medication may be right for you.

Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

Find the best new GLP-1 drug for you.

Evidence is emerging that glucagon-like peptide-1 (GLP-1) receptor agonists have anti-inflammatory and chondroprotective properties independent of their effects on weight loss

What is it and what are the pros and cons?